Analyze Diet
Veterinary research communications2016; 40(3-4); 107-115; doi: 10.1007/s11259-016-9659-4

Immunological and pathological investigations in equine experimental uveitis.

Abstract: The pathogenic mechanism of equine recurrent uveitis (ERU) is still poorly defined and many variations between experimental animal models and spontaneous disease exist. Objective: The aim of our study was to investigate if Th17 cell-mediated response plays role in the pathogenesis of the used experimental model in horses and to reveal its pathological findings. Methods: Experimental uveitis was induced in 6 healthy horses. The concentrations of retinal autoantigen CRALBP and IL-17 were measured using ELISA in aqueous humor and vitreous body of the 12 inflamed eyes as well as in 12 control non-inflamed eyes taken from 6 horses in slaughter house. After centrifugation of the two eye media, smears were prepared and cytological investigation was performed. Tissue specimens were taken from all eye globes and were submitted to histopathological investigation. Results: CRALBP and IL-17 concentrations were significantly elevated in eye media of horses with experimental uveitis in comparison with controls. Cytological and histopathological findings corresponded to the changes characteristic of chronic immune-mediated inflammation with mononuclear cell infiltration of uvea, choroid, retina, and eye media as well as severe retinal destruction. Conclusions: Our study demonstrated the involvement of the retinal autoantigen CRALBP as well as IL-17 in the pathogenesis of experimental uveitis in horses. These findings suggests that this experimental uveitis in horses may serve as a suitable animal model for investigation of IL-17- mediated immune response during spontaneous autoimmune uveitis in horses as well as in humans.
Publication Date: 2016-06-25 PubMed ID: 27344152DOI: 10.1007/s11259-016-9659-4Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study discussed in the article investigates whether the Th17 cell-mediated response plays a role in the pathogenesis of experimental uveitis in horses, comparing concentrations of retinal autoantigen CRALBP and IL-17 in inflamed and non-inflamed eyes. The results indicate a significant involvement of retinal autoantigen CRALBP and IL-17 in the pathogenesis of experimental uveitis in horses.

Objectives of the Study

  • The primary aim of this research was to understand whether a Th17 cell-mediated response has a role in the pathogenesis of an experimental model of uveitis developed in horses.
  • The researchers set out to identify any pathological findings related to the disease.

Methods to Achieve Study Objectives

  • The researchers instigated Experimental uveitis in six healthy horses.
  • They measured the concentrations of retinal autoantigen CRALBP and IL-17 using an assay called ELISA (Enzyme-linked Immunosorbent Assay) in the aqueous humor and vitreous body of the inflamed eyes as well as in non-inflamed eyes taken from six other horses.
  • Cytological and histopathological investigations were carried out on tissue specimens from all affected eyes.

Key Results and Findings

  • The study found that concentrations of both CRALBP and IL-17 were significantly higher in the eyes of horses with experimental uveitis, when compared to control animals.
  • The researchers observed cytological and histopathological evidence of chronic immune-mediated inflammation with mononuclear cell infiltration of various ocular tissues, as well as severe retinal destruction.

Conclusions and Implications of the Study

  • The elevated concentrations of the retinal autoantigen CRALBP and IL-17 in the eye media of the horses with experimentally induced uveitis suggest their involvement in the disease’s pathogenesis.
  • These findings imply that the experimental uveitis in horses could potentially serve as a useful animal model for the investigation of the role of the IL-17-mediated immune response in spontaneous autoimmune uveitis in horses and humans.

Cite This Article

APA
Simeonova GP, Krastev SZ, Simeonov RS. (2016). Immunological and pathological investigations in equine experimental uveitis. Vet Res Commun, 40(3-4), 107-115. https://doi.org/10.1007/s11259-016-9659-4

Publication

ISSN: 1573-7446
NlmUniqueID: 8100520
Country: Switzerland
Language: English
Volume: 40
Issue: 3-4
Pages: 107-115

Researcher Affiliations

Simeonova, Galina P
  • Department of Veterinary Surgery, Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria. galinavet@abv.bg.
Krastev, Svetozar Z
  • Department of Veterinary Surgery, Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria.
Simeonov, Radostin S
  • Department of General and Clinical Pathology, Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria.

MeSH Terms

  • Animals
  • Aqueous Humor / chemistry
  • Aqueous Humor / immunology
  • Carrier Proteins / analysis
  • Carrier Proteins / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Eye / physiopathology
  • Horse Diseases / immunology
  • Horse Diseases / pathology
  • Horse Diseases / physiopathology
  • Horses
  • Interleukin-17 / analysis
  • Interleukin-17 / immunology
  • Th17 Cells / immunology
  • Uveitis / immunology
  • Uveitis / pathology
  • Uveitis / physiopathology
  • Uveitis / veterinary
  • Vitreous Body / chemistry
  • Vitreous Body / immunology
  • Vitreous Body / physiopathology

References

This article includes 27 references
  1. Chen J, Qian H, Horai R, Chan CC, Falick Y, Caspi RR. Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.. PLoS One 2013;8(8):e72161.
    pubmed: 24015215doi: 10.1371/journal.pone.0072161google scholar: lookup
  2. Agarwal RK, Silver PB, Caspi RR. Rodent models of experimental autoimmune uveitis.. Methods Mol Biol 2012;900:443-69.
    pubmed: 22933083doi: 10.1007/978-1-60761-720-4_22google scholar: lookup
  3. Yi NY, Davis JL, Salmon JH, Gilger BC. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.. Vet Ophthalmol 2008 Sep;11 Suppl 1:15-9.
  4. Banerjee S, Savant V, Scott RA, Curnow SJ, Wallace GR, Murray PI. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.. Invest Ophthalmol Vis Sci 2007 May;48(5):2203-7.
    pubmed: 17460280doi: 10.1167/iovs.06-1358google scholar: lookup
  5. Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.. Arthritis Res Ther 2012 May 1;14(3):R99.
    pubmed: 22546542doi: 10.1186/ar3824google scholar: lookup
  6. Delogu LG, Deidda S, Delitala G, Manetti R. Infectious diseases and autoimmunity.. J Infect Dev Ctries 2011 Oct 13;5(10):679-87.
    pubmed: 21997935doi: 10.3855/jidc.2061google scholar: lookup
  7. de Smet MD, Bitar G, Roberge FG, Gery I, Nussenblatt RB. Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat.. J Autoimmun 1993 Oct;6(5):587-99.
    pubmed: 7694588doi: 10.1006/jaut.1993.1048google scholar: lookup
  8. Xue Y, Shen SQ, Jui J, Rupp AC, Byrne LC, Hattar S, Flannery JG, Corbo JC, Kefalov VJ. CRALBP supports the mammalian retinal visual cycle and cone vision.. J Clin Invest 2015 Feb;125(2):727-38.
    pubmed: 25607845doi: 10.1172/JCI79651google scholar: lookup
  9. Truchetet ME, Mossalayi MD, Boniface K. IL-17 in the rheumatologist's line of sight.. Biomed Res Int 2013;2013:295132.
    pubmed: 23984335doi: 10.1155/2013/295132google scholar: lookup
  10. Deeg CA. Ocular immunology in equine recurrent uveitis.. Vet Ophthalmol 2008 Sep;11 Suppl 1:61-5.
  11. Saari JC, Crabb JW. Focus on molecules: cellular retinaldehyde-binding protein (CRALBP).. Exp Eye Res 2005 Sep;81(3):245-6.
    pubmed: 16085009doi: 10.1016/j.exer.2005.06.015google scholar: lookup
  12. Deeg CA, Reese S, Gerhards H, Wildner G, Kaspers B. The uveitogenic potential of retinal S-antigen in horses.. Invest Ophthalmol Vis Sci 2004 Jul;45(7):2286-92.
    pubmed: 15223807doi: 10.1167/iovs.03-1226google scholar: lookup
  13. Maya JR, Sadiq MA, Zapata LJ, Hanout M, Sarwar S, Rajagopalan N, Guinn KE, Sepah YJ, Nguyen QD. Emerging therapies for noninfectious uveitis: what may be coming to the clinics.. J Ophthalmol 2014;2014:310329.
    pubmed: 24868451doi: 10.1155/2014/310329google scholar: lookup
  14. Deeg CA, Thurau SR, Gerhards H, Ehrenhofer M, Wildner G, Kaspers B. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease.. Eur J Immunol 2002 Sep;32(9):2598-606.
  15. Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.. Clin Dev Immunol 2013;2013:968549.
    pubmed: 23956763doi: 10.1155/2013/968549google scholar: lookup
  16. El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K, Van Damme J. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.. Clin Immunol 2011 May;139(2):177-84.
    pubmed: 21334264doi: 10.1016/j.clim.2011.01.014google scholar: lookup
  17. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH, Durez P, Tak PP, Gomez-Reino JJ, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD, Rose K, Haider A, Di Padova F. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.. Sci Transl Med 2010 Oct 6;2(52):52ra72.
    pubmed: 20926833doi: 10.1126/scitranslmed.3001107google scholar: lookup
  18. Regan DP, Aarnio MC, Davis WS, Carmichael KP, Vandenplas ML, Lauderdale JD, Moore PA. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis.. Vet Ophthalmol 2012 May;15(3):145-52.
  19. Gilger BC, Malok E, Stewart T, Horohov D, Ashton P, Smith T, Jaffe GJ, Allen JB. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.. Vet Immunol Immunopathol 2000 Oct 31;76(3-4):239-55.
    pubmed: 11044557doi: 10.1016/s0165-2427(00)00219-1google scholar: lookup
  20. Deeg CA, Raith AJ, Amann B, Crabb JW, Thurau SR, Hauck SM, Ueffing M, Wildner G, Stangassinger M. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis.. Clin Dev Immunol 2007;2007:39245.
    pubmed: 18317528doi: 10.1155/2007/39245google scholar: lookup
  21. Kulbrock M, Lehner S, Metzger J, Ohnesorge B, Distl O. A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses.. PLoS One 2013;8(8):e71619.
    pubmed: 23977091doi: 10.1371/journal.pone.0071619google scholar: lookup
  22. Deeg CA, Pompetzki D, Raith AJ, Hauck SM, Amann B, Suppmann S, Goebel TW, Olazabal U, Gerhards H, Reese S, Stangassinger M, Kaspers B, Ueffing M. Identification and functional validation of novel autoantigens in equine uveitis.. Mol Cell Proteomics 2006 Aug;5(8):1462-70.
    pubmed: 16690753doi: 10.1074/mcp.M500352-MCP200google scholar: lookup
  23. Romeike A, Brügmann M, Drommer W. Immunohistochemical studies in equine recurrent uveitis (ERU).. Vet Pathol 1998 Nov;35(6):515-26.
    pubmed: 9823593doi: 10.1177/030098589803500606google scholar: lookup
  24. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.. J Exp Med 2008 Apr 14;205(4):799-810.
    pubmed: 18391061doi: 10.1084/jem.20071258google scholar: lookup
  25. Wiggans KT, Vernau W, Lappin MR, Thomasy SM, Maggs DJ. Diagnostic utility of aqueocentesis and aqueous humor analysis in dogs and cats with anterior uveitis.. Vet Ophthalmol 2014 May;17(3):212-20.
    pubmed: 23910096doi: 10.1111/vop.12075google scholar: lookup
  26. Prete M, Dammacco R, Fatone MC, Racanelli V. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.. Clin Exp Med 2016 May;16(2):125-36.
    pubmed: 25820692doi: 10.1007/s10238-015-0345-6google scholar: lookup
  27. Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis.. Semin Immunopathol 2008 Apr;30(2):135-43.
    pubmed: 18317764doi: 10.1007/s00281-008-0108-5google scholar: lookup

Citations

This article has been cited 3 times.
  1. Dammak A, Pastrana C, Martin-Gil A, Carpena-Torres C, Peral Cerda A, Simovart M, Alarma P, Huete-Toral F, Carracedo G. Oxidative Stress in the Anterior Ocular Diseases: Diagnostic and Treatment.. Biomedicines 2023 Jan 20;11(2).
    doi: 10.3390/biomedicines11020292pubmed: 36830827google scholar: lookup
  2. Lu H, Chen DD, Zhu SQ. Therapeutic potential of pupilloplasty combined with phacomulsification and intraocular lens implantation against uveitis-induced cataract.. Int J Ophthalmol 2022;15(10):1598-1603.
    doi: 10.18240/ijo.2022.10.06pubmed: 36262864google scholar: lookup
  3. Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis.. Front Immunol 2020;11:609855.
    doi: 10.3389/fimmu.2020.609855pubmed: 33488614google scholar: lookup